Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 1, 2000

View Archived Issues

Italian Firm Novuspharma Seeks EUR177.3M In Combined Offering

Amrad Cutting Back Operations To Focus On Research Portfolio

European Scientists To Convene On Use Of Genomic Information

Fallout From Cantab Setback Continues With CEO Departure

European Commission Prepares Criteria For GMM Contained Use

Astex Signs Deal With Janssen, Plans Second Funding Round

CAT, HGS Extend Collaboration To Develop Antibodies For BLyS

Industry Seeks Change Of Focus From National To European Level

Jump In Genset's Quarterly Loss Linked To New Corporate Strategy

Medarex Increases IDM Stake Through Licensing Agreement

Uroghne Enters Research Deal, Closes Its First Funding Round

MediGene and Schering Move Cancer Vaccine Into Phase I/II

Other News To Note